American Shared Hospital Services (AMS) Stock Analysis

Company Overview

American Shared Hospital Services specializes in providing technology solutions designed for stereotactic radiosurgery and advanced radiation therapy equipment and services. The company operates within the broader healthcare sector, specifically functioning in the medical care facilities industry where it delivers critical infrastructure for radiation oncology treatments. Its operational scale is defined by a market capitalization of $11.92 million and an annual revenue of $29.42 million, supported by an workforce of 81 employees. These valuation and revenue figures indicate that the company is a small-cap entity with a niche focus, suggesting a limited but specialized market position relative to large-cap healthcare infrastructure providers.

Financial Health

The company generated revenue of $29.42 million over the trailing twelve months while reporting a net income loss of $2,250,000 and an EBITDA of $6.64 million. The substantial gap between the positive EBITDA of $6.64 million and the negative net income of $-2,250,000 reveals a significant cost structure burden, likely driven by high interest expenses associated with its debt load or non-operating costs. Free cash flow stands at $-15,763,625, which indicates a lack of financial flexibility to fund internal growth or pay down debt from operational cash generation alone. The gross margin is reported at 45.5%, reflecting a relatively efficient cost of goods sold for the leasing and retail segments, whereas the operating margin is only 0.7%, suggesting high overhead costs relative to operating revenue. The profit margin is negative at -7.6%, confirming that the company is currently unprofitable on a bottom-line basis. On the balance sheet, total cash holdings of $5.09 million are insufficient to cover total debt of $24.62 million, resulting in a debt-to-equity ratio of 86.07, which characterizes the balance sheet as highly leveraged rather than conservative. The current ratio is 1.20, indicating that the company holds sufficient current assets to cover its short-term liabilities, though the margin of safety is narrow. Return on equity is -11.9% and return on assets is 0.6%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate positive returns.

Valuation Assessment

The trailing twelve-month P/E ratio is N/A due to negative earnings, while the forward P/E is listed at 4.54, implying that the market is pricing the stock based on expected future earnings rather than current performance. The price-to-book ratio is 0.48, indicating that the market values the company at less than half of its net asset book value, which suggests a deep discount or significant market skepticism regarding future cash flows. The price-to-sales ratio is 0.41, and the EV/EBITDA is 5.33; these alternative valuation metrics suggest the stock is priced on a very low multiple relative to its sales and earnings power before interest and taxes. The stock has a 52-week high of $3.11 and a 52-week low of $1.81, meaning the current price sits within a range where the stock has experienced significant volatility over the last year. The beta value is 0.13, which indicates that the stock's price volatility is significantly lower than the broader market, behaving as a defensive or low-correlation asset during market swings.

Growth & Income

Revenue growth year-over-year is 2.5%, while earnings growth is N/A given the current unprofitability, which implies that top-line expansion is occurring without yet translating into bottom-line profitability. The company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning it does not distribute income to shareholders. Instead of paying dividends, the company retains its earnings, though the negative net income limits the ability to use these retained earnings for growth or share repurchases. The overall growth and income profile is characterized by modest revenue expansion coupled with significant profitability challenges and no current income generation for investors.